Home > Income Statement > MARKSANS PHARMA

MARKSANS PHARMA
Consolidated Net Profit

    Back to Income Statement
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹381 Cr₹314 Cr₹266 Cr₹185 Cr₹236 Cr

What is the latest Consolidated Net Profit of MARKSANS PHARMA ?

The latest Consolidated Net Profit ratio of MARKSANS PHARMA is ₹381 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹381 Cr
Mar2025₹314 Cr
Mar2024₹266 Cr
Mar2023₹185 Cr
Mar2022₹236 Cr

How is Consolidated Net Profit of MARKSANS PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹381 Cr
21.32
Mar2025 ₹314 Cr
17.80
Mar2024 ₹266 Cr
44.29
Mar2023 ₹185 Cr
-21.77
Mar2022 ₹236 Cr -

Compare Consolidated Net Profit of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹14,368.7 Cr -2.5% -4.1% 91.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,466.0 Cr -0.8% -5.1% 6.3% Stock Analytics
DIVIS LABORATORIES ₹246,222.0 Cr -3.2% -1.4% 53.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,300.0 Cr -1.6% -6% 32.1% Stock Analytics
CIPLA ₹107,447.0 Cr 0% -3.6% -13.2% Stock Analytics
DR REDDYS LABORATORIES ₹103,471.0 Cr 3.1% 8.7% -1.5% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-2.5%

-4.1%

91.1%

SENSEX

-0.1%

-2.3%

-10.7%


You may also like the below Video Courses